Cassava Sciences Inc (SAVA)

$2.12 +0.09 (4.43%)
Market Cap 98.07M
Revenue (ttm) 0.00
Net Income (ttm) -24.34M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 853,300
Avg Vol 1,012,400
Day's Range N/A - N/A
Shares Out 48.31M
Stochastic %K 42%
Beta -1.00
Analysts Strong Buy
Price Target $2.00

Company Profile

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company w...

Industry: Biotechnology
Sector: Healthcare
Phone: 512 501 2444
Address:
6801 N. Capital of Texas Highway, Suite 300 Building 1, Austin, United States
deetmesquite
deetmesquite Jan. 27 at 11:10 PM
$TXN Guys like this crack me up, got him declaring victory over everyone meanwhile…. He’s down on $DJT and has been banging the $TXN play since he bought the top last time. Got to hand it to him for not selling, enjoy the W! Hope you can make back some of your $DJT and $SAVA losses big guy.
0 · Reply
Dew8
Dew8 Jan. 27 at 2:12 AM
$SAVA still got my bag at 20
1 · Reply
BillionerOfKing
BillionerOfKing Jan. 26 at 7:43 PM
$SAVA Current Stock Price: $2.10 Contracts to trade: $0.5 SAVA Jan 30 2026 Call Entry: $1.52 Exit: $2.38 ROI: 57% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Moneymachineuser
Moneymachineuser Jan. 26 at 6:50 AM
$SAVA crazy to think ppl bag holding $30+
1 · Reply
bobbythek
bobbythek Jan. 23 at 5:24 PM
$SAVA Maximum pain for options expiration today is $2. That is why pressure today. Great opportunity to add as they try to suppress price today.
1 · Reply
StRicchionazzi
StRicchionazzi Jan. 23 at 5:19 PM
$SAVA something’s cooking
0 · Reply
JasonJonathan
JasonJonathan Jan. 23 at 4:10 PM
$SAVA there has to be some imminent news..
1 · Reply
bobbythek
bobbythek Jan. 23 at 1:30 PM
$SAVA With that new trademark filing, could they be preparing to offer their alzheimers drug off label? It was proved safe, and pretty good anecdotal success..
2 · Reply
whydididothat
whydididothat Jan. 23 at 12:32 PM
$SAVA undecided on selling when over a little than average?🤔
1 · Reply
glenn009
glenn009 Jan. 23 at 3:25 AM
$ADTX Holy Grail pattern INCOMING!! 🚀💥💯 "I have spoken." $IBRX $LIXT $SAVA
0 · Reply
Latest News on SAVA
HALPER SADEH LLC ENCOURAGES CASSAVA SCIENCES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dec 24, 2025, 11:51 AM EST - 4 weeks ago

HALPER SADEH LLC ENCOURAGES CASSAVA SCIENCES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

FDA Puts Cassava's Simufilam Epilepsy Trial On Full Clinical Hold

Dec 19, 2025, 11:31 AM EST - 5 weeks ago

FDA Puts Cassava's Simufilam Epilepsy Trial On Full Clinical Hold

Halper Sadeh LLC Encourages Cassava Sciences, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 22, 2025, 4:05 PM EDT - 3 months ago

Halper Sadeh LLC Encourages Cassava Sciences, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Cassava Sciences Appoints Dawn C. Bir to the Board of Directors

Oct 22, 2025, 8:00 AM EDT - 3 months ago

Cassava Sciences Appoints Dawn C. Bir to the Board of Directors

Cassava Reports Q2 2025 Financials Results and Provides Business Update

Aug 14, 2025, 7:30 AM EDT - 5 months ago

Cassava Reports Q2 2025 Financials Results and Provides Business Update

Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer

Aug 7, 2025, 7:30 AM EDT - 6 months ago

Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer

Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy

Aug 4, 2025, 7:30 AM EDT - 6 months ago

Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy

Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting

Jun 30, 2025, 7:00 AM EDT - 7 months ago

Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC

May 1, 2025, 7:30 AM EDT - 9 months ago

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC

Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

Apr 21, 2025, 4:30 PM EDT - 10 months ago

Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

Cassava Sciences must face malicious prosecution lawsuit over Alzheimer's drug

Mar 26, 2025, 3:49 PM EDT - 10 months ago

Cassava Sciences must face malicious prosecution lawsuit over Alzheimer's drug

Cassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop

Mar 25, 2025, 10:42 AM EDT - 11 months ago

Cassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

Mar 25, 2025, 8:05 AM EDT - 11 months ago

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

Cassava Sciences Reports 2024 Financial Results and Provides Business Update

Mar 3, 2025, 7:30 AM EST - 11 months ago

Cassava Sciences Reports 2024 Financial Results and Provides Business Update

Lead Plaintiff Deadline on February 10, 2025 for SAVA Investors - Kessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm

Feb 9, 2025, 10:45 AM EST - 1 year ago

Lead Plaintiff Deadline on February 10, 2025 for SAVA Investors - Kessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm

SAVA Deadline: Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Feb 7, 2025, 12:08 PM EST - 1 year ago

SAVA Deadline: Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA

Feb 3, 2025, 5:45 AM EST - 1 year ago

Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava

Jan 23, 2025, 2:47 PM EST - 1 year ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava

Cassava Sciences Provides a Business Update

Jan 7, 2025, 4:30 PM EST - 1 year ago

Cassava Sciences Provides a Business Update

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. Lawsuit - SAVA

Dec 23, 2024, 5:45 AM EST - 1 year ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. Lawsuit - SAVA

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava

Dec 18, 2024, 10:53 AM EST - 1 year ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava

Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Dec 13, 2024, 1:16 PM EST - 1 year ago

Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

deetmesquite
deetmesquite Jan. 27 at 11:10 PM
$TXN Guys like this crack me up, got him declaring victory over everyone meanwhile…. He’s down on $DJT and has been banging the $TXN play since he bought the top last time. Got to hand it to him for not selling, enjoy the W! Hope you can make back some of your $DJT and $SAVA losses big guy.
0 · Reply
Dew8
Dew8 Jan. 27 at 2:12 AM
$SAVA still got my bag at 20
1 · Reply
BillionerOfKing
BillionerOfKing Jan. 26 at 7:43 PM
$SAVA Current Stock Price: $2.10 Contracts to trade: $0.5 SAVA Jan 30 2026 Call Entry: $1.52 Exit: $2.38 ROI: 57% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Moneymachineuser
Moneymachineuser Jan. 26 at 6:50 AM
$SAVA crazy to think ppl bag holding $30+
1 · Reply
bobbythek
bobbythek Jan. 23 at 5:24 PM
$SAVA Maximum pain for options expiration today is $2. That is why pressure today. Great opportunity to add as they try to suppress price today.
1 · Reply
StRicchionazzi
StRicchionazzi Jan. 23 at 5:19 PM
$SAVA something’s cooking
0 · Reply
JasonJonathan
JasonJonathan Jan. 23 at 4:10 PM
$SAVA there has to be some imminent news..
1 · Reply
bobbythek
bobbythek Jan. 23 at 1:30 PM
$SAVA With that new trademark filing, could they be preparing to offer their alzheimers drug off label? It was proved safe, and pretty good anecdotal success..
2 · Reply
whydididothat
whydididothat Jan. 23 at 12:32 PM
$SAVA undecided on selling when over a little than average?🤔
1 · Reply
glenn009
glenn009 Jan. 23 at 3:25 AM
$ADTX Holy Grail pattern INCOMING!! 🚀💥💯 "I have spoken." $IBRX $LIXT $SAVA
0 · Reply
JamesBenjaMin
JamesBenjaMin Jan. 22 at 11:45 PM
Watch SVRE this one could get wild next week TOP INVENTIONS OF 2025 with defense ties! 350% cost to borrow $RR $CAPT $SAVA $QCLS
0 · Reply
CaesarZane
CaesarZane Jan. 22 at 9:57 PM
$VKTX $SAVA $SANA 🚀🚀🚀 https://youtu.be/_qe2uX_xu38
0 · Reply
ACInvestorBlog
ACInvestorBlog Jan. 22 at 9:45 PM
$SAVA is bottoming out
0 · Reply
Yoho666
Yoho666 Jan. 22 at 9:12 PM
$SAVA yes rise without a reason just means it will back to 2 below shortly.
1 · Reply
DK_72
DK_72 Jan. 22 at 9:07 PM
$SAVA I like it but I can’t see the reason
0 · Reply
Elaine_Shrimp
Elaine_Shrimp Jan. 22 at 9:03 PM
$SAVA next swing idea
0 · Reply
ACInvestorBlog
ACInvestorBlog Jan. 22 at 8:56 PM
$SAVA added , just in case. Bullish option flow today
0 · Reply
Bricktop200
Bricktop200 Jan. 22 at 8:55 PM
$SAVA the name is a term for the protein they use in studies. Filamin A
0 · Reply
ACInvestorBlog
ACInvestorBlog Jan. 22 at 8:47 PM
$SAVA now it makes sense ... Insiders purchased a ton of shares in November..... something is brewing ...
0 · Reply
Bricktop200
Bricktop200 Jan. 22 at 8:47 PM
$SAVA I’ll take some more thanks
0 · Reply
ACInvestorBlog
ACInvestorBlog Jan. 22 at 8:42 PM
$SAVA filed a new trademark for "FILANA THERAPEUTICS" https://tsdr.uspto.gov/#caseNumber=99602139&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
0 · Reply
TradeHawk
TradeHawk Jan. 22 at 8:39 PM
$SAVA Cassava Sciences filed a new trademark for "FILANA THERAPEUTICS". Possible rebrand or maybe something else coming. https://tsdr.uspto.gov/#caseNumber=99602139&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
0 · Reply